Literature DB >> 1673872

Comparison of liver cancer and nodules induced in rats by deoxycholic acid diet with or without prior initiation.

D Armstrong1, R G Cameron.   

Abstract

The neoplastic responses of liver to prolonged continuous exposures of deoxycholic acid (DCA) in the diet with or without prior initiation was examined in Fischer 344 (F-344) and Sprague-Dawley (SD) male rats. In both rat strains, 7 months of continuous feeding of 0.5% (F-344 rats) or 1.0% (SD rats) of deoxycholic acid in chow diet generated hepatic nodules which persisted up to 8 months after deoxycholic acid was stopped. In one group of Sprague-Dawley male rats, 7 months of deoxycholic acid was preceded by an initiating dose of diethylnitrosamine. In 10 out of 15 of these rats, not only persistent nodules but also 26 liver cancers (large, multifocal, invasive, lung metastases) become evident by 8 months after cessation of deoxycholic acid.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673872     DOI: 10.1016/0304-3835(91)90209-z

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

Review 1.  Regulation and functional roles of chemokines in liver diseases.

Authors:  Sheng Cao; Mengfei Liu; Tejasav S Sehrawat; Vijay H Shah
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-11       Impact factor: 73.082

2.  Commentary: Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.

Authors:  Baolei Jia
Journal:  Front Immunol       Date:  2019-02-20       Impact factor: 7.561

Review 3.  Promotion and induction of liver cancer by gut microbiome-mediated modulation of bile acids.

Authors:  Baolei Jia; Che Ok Jeon
Journal:  PLoS Pathog       Date:  2019-09-05       Impact factor: 6.823

4.  Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis.

Authors:  Yanqiao Wu; Nagaraja Sreeharsha; Sanjay Sharma; Anurag Mishra; Avinash Kumar Singh; Shiva Kumar Gubbiyappa
Journal:  ACS Omega       Date:  2020-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.